Page 3 - SaxoCell Annual Report 2021
P. 3
2021 in brief
We are SaxoCell® - the Saxon innovation cluster for Cell and Gene Therapy (CGT)
funded by the BMBF Clusters4Future initiative. SaxoCell brings together many
academic and corporate partners to develop and improve CGT-based therapies for
serious diseases. In this annual report, we would like to highlight SaxoCell's launch
into the implementation phase as a cluster for future in October, 2021. All partners
came together virtually for the kick-off event on November 16 and all projects have
commenced activities in their ambitious endeavours. We have had the privilege to
host a pioneer in gene therapy, Alain Fischer from the Imagine Institute of the
College de France in Paris in October, and the honour to have Matthias Hebrok from
the Diabetes Center of the University of California in San Francisco as a guest
professor for four months. Our public relations team has been busy delivering our
website, press releases and SaxoCell Newsletters.
In things to come in 2022, SaxoCell will be on display at the ARM Med, the German
Biotechnology Days and the ISCT meetings and will feature prominently at the BIO-
Europe held in Leipzig from October 24-26. Our first consortium meeting is taking
place in June and we look forward to presenting our achievements to our External
Advisory Board later this year.
